The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.

Swedish stakeholders have broadly welcomed the CMA, but some question its competition mechanics and the import dynamics for ...

A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

This funding will likely only cover the coordination efforts of the European Medicines Agency (EMA) and the European ...

The European Commission (EC) and the Medicines and Healthcare products Regulatory Agency (MHRA) have approved sugemalimab in combination with platinum-based chemotherapy for the first-line ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel, March ...

Apitegromab is an investigational treatment aimed at improving motor function for people living with spinal muscular atrophy. Scholar Rock said it has also submitted and received validation for its ...